CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Q2 2026 vs. Q1 2026
How the institutions holding CDT Equity Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 2 | 8 | +6 |
| Shares | 112 | 169.5K | +169.4K (+151,225.9%) |
| Value | $571 | $94.7K | +$94.1K (+16,476.9%) |
New holders (7)
Institutions that held CDT Equity Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 61,190 | $34.3K | 0.00% |
| Citadel Advisors LLC | 32,295 | $18.1K | 0.00% |
| Virtu Financial LLC | 27,244 | $15.0K | 0.00% |
| Geode Capital Management, LLC | 16,739 | $9.37K | 0.00% |
| XTX Topco Ltd | 12,916 | $7.23K | 0.00% |
| Financial Management Professionals, Inc. | 10,005 | $5.60K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% |
Sold out (1)
Institutions that held CDT Equity Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Morgan Stanley | 2 | $10 |